Search for: "ABBOTT v. ABBOTT" Results 1641 - 1660 of 2,570
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2011, 12:43 pm by Jake Ward
(CAFC 2011, Appeal 2008-1511) The en banc CAFC decision in Therasense v. [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
24 May 2011, 1:44 pm
Kyrillos Vote Against LaVecchia Justified State Senator Joe Kyrillos (R- Monmouth/Middlesex) issued the following statement denouncing the State Supreme Court’s decision in the latest round of Abbott v. [read post]
22 May 2011, 8:41 pm by Patent Docs
Abbott Products Inc. et al. v. [read post]
20 May 2011, 7:57 am by Stefanie Levine
The week also saw yet another round in the war between Abbott Diabetes Care and DexCom over analyte sensors (see ex parte Request No. (5)). [read post]
19 May 2011, 9:12 pm
In Abbott Laboratories v. [read post]
9 May 2011, 8:09 am by Justin Boley, Associate
”[6] Sources: [1] Advanced Medical Optics was purchased by Abbott Laboratories and has since been re-named [read post]
4 May 2011, 4:13 am by Marie Louise
(Patent Law Practice Center) US: Abraxis files for patent term adjustment calculation review for patent entitled ‘Compositions and methods of delivery of pharmacological agents’ (Patent Docs) US: ITC: Target date set in Certain Vaginal Ring Birth Control Devices (ITC 337 Law Blog) US: Court confused by patent reexamination results: Cellectricon v Fluxion Biosciences (Patents Post-Grant) Products AndroGel (Testosterone) – US: Abbott sues Teva in attempt to block US… [read post]
27 Apr 2011, 4:55 am by Marie Louise
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent… [read post]
22 Apr 2011, 11:56 am by Stefanie Levine
Filed April 8, 2011, by Abbott Diabetes Care. (9) 90/011,636 (electronically filed) - U.S. [read post]